Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhPDGF-BB-Enhanced Collagen Plug for Complex Perianal Fistula Healing
NCT06632418Phase 2Completed
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of becaplermin in perianal fistula (2 arms). Primary endpoint: Number of Participants Without Treatment-Related Serious Adverse Events at 3 months. Started Nov 2024; status: completed.
02
Drugs
becaplermin
03
Conditions
perianal fistula
Beyond the preview
Go deeper on NCT06632418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06632418.